The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.
about
CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)MHC class II tetramersNatural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokinesA three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaquesHuman leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals.Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9.Anthrax lethal toxin and the induction of CD4 T cell immunity.Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring.Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.The IL-23/Th17 axis is involved in the adaptive immune response to Bacillus anthracis in humans.A field usable qualitative anti-protective antigen enzyme-linked immunosorbent assay for serodiagnosis of human anthrax.A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
P2860
Q33769076-FCA22F12-1A55-467D-B731-FF14CE2E08FFQ34047191-22D4C412-8D80-4C71-A038-AC55EAAE0D97Q34258556-F036596C-A4BF-47A7-A6B3-A00F3E0D3A15Q35726627-485C7B2F-D125-44F4-8646-A9672CDDC7FCQ36378590-F05C232D-5570-43C3-87AE-B3D749D1A1C7Q36970735-000E9DB7-24AE-454E-90F7-50EC621F85FBQ37090141-D401408E-A56A-4F7E-B0E8-2191506DA064Q37707872-BDC828A5-72CA-439E-98A3-A55EBA785227Q38060730-70E628ED-EB6E-4649-93FF-C6C43E3EC983Q38927379-CA837CB2-C6E0-45CC-8BED-057CFCDBD3AEQ39228782-211374E4-5931-4B33-BD8F-FD73765B97E7Q39846065-746D25E9-3C99-4AED-AD0A-9F9B3F83F875Q42164969-DF0B7DCE-AC0C-4EB0-84D9-3ECDCF5F317BQ44947492-71F92383-3636-410D-9BF6-EE7EC8849629Q54217728-76ED8F89-D44F-4F47-BE35-38CD0526A272
P2860
The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The anthrax vaccine adsorbed v ...... from that of naive PA T cells.
@en
type
label
The anthrax vaccine adsorbed v ...... from that of naive PA T cells.
@en
prefLabel
The anthrax vaccine adsorbed v ...... from that of naive PA T cells.
@en
P2093
P2860
P356
P1476
The anthrax vaccine adsorbed v ...... from that of naive PA T cells.
@en
P2093
Andrew R Wiesen
Junbao Yang
Laurie Huston
Michelle Roti
William W Kwok
P2860
P304
P356
10.1128/IAI.00324-08
P407
P50
P577
2008-08-04T00:00:00Z